6 March 2019 - China's recent policy to increase patients' access to cancer medicines has helped more people receive quality treatment, said the Beijing-based newspaper Health News Wednesday.

The Chinese government has introduced several policies to reduce cancer patients' medical expenses and increase the supply of the latest cancer medicines.

In October 2018, 17 cancer drugs widely used in tumour treatment were included in China's national basic health care system and saw an average price slash of 56.7%, after a three-month negotiation between the government and domestic and foreign pharmaceutical companies.

Read Xinhuanet article